Nordic study reveals stark gaps in how heart patients stick with blood thinners

Researchers found significant differences across Denmark, Sweden, Norway, and Finland in how long atrial fibrillation patients stay on oral anticoagulation therapy—and those differences directly affect stroke and mortality outcomes. The findings suggest healthcare systems can learn from each other to improve treatment adherence and patient safety.

Originaltitel: Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland